Experts Discuss Benefits and Risks of Panels, Exomes, Whole Genomes for Diagnostics | GenomeWeb

With an ever-increasing number of options for diagnostic sequencing, the decision of whether to do a gene panel, exome, or whole genome becomes complicated. At the Cambridge Healthtech Institute's Clinical Genome Conference in San Francisco last week, a number of experts in the molecular diagnostics and next-generation sequencing industry discussed the benefits and limitations of the various options.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.